Hepatitis B virus infection is a global health problem. Worldwide, about 360 million people are chronically infected with the virus. They continue to spread the virus to others and are themselves at risk of chronic liver diseases and hepatocellular carcinoma. The infection can now be treated by antivirals or interferons and the transmission route can be interrupted. Nevertheless, the most effective means is to immunize all susceptible individuals, especially young children, with safe and efficacious vaccines . The combined efforts of vaccination, effective treatment and interruption of transmission make elimination of the infection plausible and may eventually lead to eradication of the virus. Because hepatitis B vaccination has a key role ...
Viral hepatitis B is a leading cause of acute and chronic liver disease worldwide, including cirrhos...
The major cause of liver cancer around the globe is hepatitis B virus (HBV), which also contributes ...
Hepatitis B vaccine (HepB), which has been available since 1982, provides lifelong protection agains...
Hepatitis B virus infection is a global health problem. Worldwide, about 360 million people are chro...
Hepatitis B is a disease that affects people throughout the world, and over 200 million are persiste...
Hepatitis B virus (HBV) infection is a global health threat; with 240 million people are chronic car...
About 3-5 % of the world's population is chronically infected by hepatitis B virus (HBV) and is at r...
Worldwide, two billion people have been infected with hepatitis B virus (HBV), 360 million have chro...
Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million pe...
The primary goal of hepatitis B prevention programs is reduction of chronic hepatitis B virus (HBV) ...
Current issues that are associated with the development of hepatitis B vaccine, combination vaccine...
Hepatitis B virus (HBV) infection is a world wide public health problem of major concern. HBV infect...
The major cause of liver cancer around the globe is hepatitis B virus (HBV), which also contributes ...
Hepatitis B virus (HBV) causes life-threatening liver disease. It is transmitted through a horizonta...
Hepatitis B virus (HBV) is the most important cause of hepatitis both in children and adults. Hepati...
Viral hepatitis B is a leading cause of acute and chronic liver disease worldwide, including cirrhos...
The major cause of liver cancer around the globe is hepatitis B virus (HBV), which also contributes ...
Hepatitis B vaccine (HepB), which has been available since 1982, provides lifelong protection agains...
Hepatitis B virus infection is a global health problem. Worldwide, about 360 million people are chro...
Hepatitis B is a disease that affects people throughout the world, and over 200 million are persiste...
Hepatitis B virus (HBV) infection is a global health threat; with 240 million people are chronic car...
About 3-5 % of the world's population is chronically infected by hepatitis B virus (HBV) and is at r...
Worldwide, two billion people have been infected with hepatitis B virus (HBV), 360 million have chro...
Hepatitis B virus (HBV) infection is a major public health problem, with an estimated 296 million pe...
The primary goal of hepatitis B prevention programs is reduction of chronic hepatitis B virus (HBV) ...
Current issues that are associated with the development of hepatitis B vaccine, combination vaccine...
Hepatitis B virus (HBV) infection is a world wide public health problem of major concern. HBV infect...
The major cause of liver cancer around the globe is hepatitis B virus (HBV), which also contributes ...
Hepatitis B virus (HBV) causes life-threatening liver disease. It is transmitted through a horizonta...
Hepatitis B virus (HBV) is the most important cause of hepatitis both in children and adults. Hepati...
Viral hepatitis B is a leading cause of acute and chronic liver disease worldwide, including cirrhos...
The major cause of liver cancer around the globe is hepatitis B virus (HBV), which also contributes ...
Hepatitis B vaccine (HepB), which has been available since 1982, provides lifelong protection agains...